Freeline Therapeutics Holdings plc Restructuring Charges
Freeline Therapeutics Holdings plc reported Restructuring Charges of $1.34 million for the 9-month period ending 2023-09-30, per its 6-K filed 2023-12-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2023-12-01
- Freeline Therapeutics Holdings plc restructuring charges for the quarter ending 2023-09-30 was $63.00K.
- Freeline Therapeutics Holdings plc restructuring charges for the quarter ending 2023-06-30 was $139.00K.
- Freeline Therapeutics Holdings plc restructuring charges for the quarter ending 2023-03-31 was $1.14M.
- Freeline Therapeutics Holdings plc restructuring charges for the quarter ending 2021-12-31 was $2.10M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $63.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-12-01 | $202.00K derived: sum of 2 quarters · filed 2023-12-01 | $1.34M 6-K · filed 2023-12-01 | ||
| 2023-06-30 | $139.00K derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | $1.28M 6-K · filed 2023-08-15 | |||
| 2023-03-31 | $1.14M 6-K · filed 2023-05-30 | ||||
| 2022-12-31 | $1.59M 20-F · filed 2023-04-04 | ||||
| 2021-12-31 | $2.10M 20-F · filed 2023-04-04 | $2.40M 20-F · filed 2022-03-31 | $2.38M 20-F · filed 2023-04-04 |